AnatomyOrganismsDiseasesAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesHealth Care
Cardiac Resynchronization Therapy DevicesCardiac Resynchronization TherapyCardiac Pacing, ArtificialPacemaker, ArtificialHeart FailureDefibrillators, ImplantableBundle-Branch BlockCoronary SinusVentricular Dysfunction, LeftRalstonia pickettiiVentricular RemodelingStroke VolumeTreatment OutcomeHeart VentriclesProsthesis ImplantationEchocardiographyElectrocardiographyElectrodes, ImplantedVentricular Function, LeftCardiomyopathy, DilatedEchocardiography, DopplerHeart Conduction SystemArrhythmias, CardiacCardiac Output, LowCicatrixVentricular Dysfunction

Endocardial acceleration (sonR) vs. ultrasound-derived time intervals in recipients of cardiac resynchronization therapy systems. (17/116)

 (+info)

Left ventricular lead implantation at a phrenic stimulation site is safe and effective. (18/116)

 (+info)

Initial clinical experience with implantation of left ventricular lead guided by Overlay Ref for the treatment of congestive heart failure. (19/116)

 (+info)

Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial. (20/116)

 (+info)

Use of a quadripolar left ventricular lead to achieve successful implantation in patients with previous failed attempts at cardiac resynchronization therapy. (21/116)

 (+info)

Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). (22/116)

 (+info)

Gender bias in studies for Food and Drug Administration premarket approval of cardiovascular devices. (23/116)

 (+info)

Impact of VV optimization in relation to left ventricular lead position: an acute haemodynamic study. (24/116)

 (+info)